0

Edaravone: A New Drug Approved for ALS

Jeffrey D Rothstein

Cell. 2017 Nov 2;171(4):725.

PMID: 29100067

Abstract:

Amyotrophic lateral sclerosis (ALS) is a progressive, adult onset neurodegenerative disease that is always fatal. The history of ALS drug discovery is fraught with many stops and starts. It took 22 years after the FDA approval of the anti-excitotoxic drug Riluzole before another drug was found to be effective in altering ALS progression: the anti-oxidant Edaravone.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP303019694 4-[(9-Anthracenylmethylene)amino]-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one 4-[(9-Anthracenylmethylene)amino]-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one 303019-69-4 Price
qrcode